Table 1 Characteristics of the HIV-1-infected study participants
From: HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
Subject | Age | Sex | CD4 count (cells/mm3) | VL (RNA/ml) | TC (mg/dl) | HDL (mg/dl) | LDL (mg/dl) | TG (mg/dl) | HII (sham) | HII (L-4F) | ART |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 25 | M | 367 | < 50 | 135 | 51 | 66 | 91 | 2.45 | 0.75 | AZV, RTV, TDF, FTC |
2 | NA | M | NA | NA | NA | NA | NA | NA | 2.69 | 1.19 | NA |
3 | 57 | M | 499 | < 50 | 159 | 31 | 77 | 254 | 1.01 | 0.69 | EFV, ABC, 3TC |
4 | 44 | M | 540 | < 50 | NA | NA | NA | NA | 2.73 | 0.96 | TDF, FTC, RTV, FPV |
5 | 44 | M | 540 | < 50 | 286 | 26 | 212 | 240 | 2.55 | 0.93 | TDF, FTC, AZV, RTV |
6 | 46 | M | 571 | < 50 | 184 | 52 | 108 | 121 | 1.82 | 0.89 | NA |
7 | 47 | M | 966 | < 50 | 176 | 52 | 122 | 100 | 2.61 | 0.86 | TDF, FTC, NVP |
8 | 31 | M | 553 | < 50 | 205 | 76* | 109 | 98 | 1.24 | 0.64 | EFV, FTC, TDF |
9 | 21 | M | 712 | < 50 | 169 | 64* | 93 | 58 | 1.95 | 1.00 | EFV, FTC, TDF |
10 | 62 | M | 605 | < 50 | 167 | 44 | 88 | 176 | 2.57 | 1.00 | LPV, RTV, 3TC ETV |